Five notes:
1. Orthopedic sales in the second quarter were $557 million, a 53 percent increase compared to $364 million in the same time last year.
2. Knee implant sales grew 65.5 percent to$226 million in the second quarter. Hip implants hit $161 million, a 43.6 percent increase compared to the same period last year. The trauma and extremities segment grew 44.3 percent with $149 million in sales.
3. Other reconstruction, which includes the Cori joint replacement robot, saw $21 million in sales, a 72 percent year-over-year increase.
4 The company’s sports medicine joint repair business grew 63.6 percent to$211 million in sales. Arthroscopic enabling technologies grew 53 percent, bringing in $147 in revenue.
5. Smith+Nephew’s total revenue in the second quarter grew 48.2 percent, and the company posted $1.3 billion, compared to $901 million in the same period last year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
